AGIOS PHARMACEUTICALS, INC. Quarterly Depreciation in USD from Q1 2013 to Q1 2020

Taxonomy & unit
us-gaap: USD
Description
The amount of expense recognized in the current period that reflects the allocation of the cost of tangible assets over the assets' useful lives. Includes production and non-production related depreciation.
Summary
Agios Pharmaceuticals, Inc. annual/quarterly Depreciation history and growth rate from Q1 2013 to Q1 2020.
  • Agios Pharmaceuticals, Inc. Depreciation for the quarter ending March 31, 2020 was $2.47M, a 23.4% increase year-over-year.
  • Agios Pharmaceuticals, Inc. annual Depreciation for 2023 was $6.6M, a 21.4% decline from 2022.
  • Agios Pharmaceuticals, Inc. annual Depreciation for 2022 was $8.4M, a 4.55% decline from 2021.
  • Agios Pharmaceuticals, Inc. annual Depreciation for 2021 was $8.8M, a 6.38% decline from 2020.
Depreciation, Quarterly (USD)
Depreciation, YoY Quarterly Growth (%)
Period TTM Value Value YoY Chg Change % Start Date End Date Report Filed
Q1 2020 $2.47M +$469K +23.4% Jan 1, 2020 Mar 31, 2020 10-Q 2020-04-30
Q1 2019 $2.01M +$280K +16.2% Jan 1, 2019 Mar 31, 2019 10-Q 2020-04-30
Q1 2018 $1.73M +$134K +8.42% Jan 1, 2018 Mar 31, 2018 10-Q 2019-05-02
Q1 2017 $1.59M +$345K +27.7% Jan 1, 2017 Mar 31, 2017 10-Q 2018-05-04
Q1 2016 $1.25M +$876K +237% Jan 1, 2016 Mar 31, 2016 10-Q 2017-05-04
Q1 2015 $370K +$38K +11.4% Jan 1, 2015 Mar 31, 2015 10-Q 2016-05-09
Q1 2014 $332K -$17K -4.87% Jan 1, 2014 Mar 31, 2014 10-Q 2015-05-11
Q1 2013 $349K Jan 1, 2013 Mar 31, 2013 10-Q 2014-05-09
* An asterisk sign (*) next to the value indicates that the value is likely invalid.